Joel S. Marcus

Co-Founder at Alexandria Real Estate Equities, Inc.

Joel S. Marcus

Joel S. Marcus

Co-Founder at Alexandria Real Estate Equities, Inc.

Career Highlights

Kirin-Amgen, Inc.
Alexandria Real Estate Equities, Inc.
Alexandria Venture Investments LLC

RelSci Relationships


Number of Boards






Number of Awards


Contact Data
Trying to get in touch with Joel S. Marcus? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
RelSci Relationships are individuals Joel S. Marcus likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Managing Director & Chief Executive Officer at Accelerator Services Corp.

Relationship likelihood: Strong

Founder, Chairman, President & Chief Executive Officer at Intra-Cellular Therapies, Inc.

Relationship likelihood: Strong

Senior Managing Partner, Pfizer Ventures, Vice President, Worldwide Business Development at Pfizer, Inc.

Relationship likelihood: Strong

Executive Chairman at Surface Logix LLC

Relationship likelihood: Strong

Executive Chair at Atara Biotherapeutics, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer & Co-Chief Investment Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Co-Chief Executive Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

President & Chief Financial Officer at Alexandria Real Estate Equities, Inc.

Relationship likelihood: Strong

Co-Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former President & Executive Director at Foundation for the National Institutes of Health, Inc.

Relationship likelihood: Strong

Paths to Joel S. Marcus
Potential Connections via
Relationship Science
Joel S. Marcus
Co-Founder at Alexandria Real Estate Equities, Inc.

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.


UCLA School of Law is the youngest top law school in the nation. After more than 60 years, our school has never felt bound by outmoded ideas of how law should be taught or studied. Instead, beginning in the 1950s, UCLA created its own tradition - a tradition of innovation.


NAREIT®, the National Association of Real Estate Investment Trusts®, is the worldwide representative voice for REITs and publicly traded real estate companies with an interest in U.S. real estate and capital markets. NAREIT's members are REITs and other businesses throughout the world that own, operate, and finance income-producing real estate, as well as those firms and individuals who advise, study, and service those businesses.


The participating CEOs lead companies that collectively employ more than five million people, generate more than $2 trillion in annual revenue, and represent 11 countries and a diverse group of industries.

Career History
1986 - 1994

Emphasis in business, real estate, sports law, products liability, construction and banking litigation.

CPA & Tax Manager

In 1906 Mr. Arthur Young formed an accounting firm, Arthur Young & Company, with his brother Stanley.

2003 - Prior

Accelerator Corp. invests in emerging life sciences opportunities. Through the global activities of their affiliates, the firm has access to new technologies and commercial opportunities developed at leading research institutions, universities and biotechnology companies around the world. Accelerator Corp. looks for companies that are milestone-driven and have a set of objectives designed to advance novel technologies rapidly from discovery to a proof-of-concept development stage that supports further financing.

Boards & Committees
Member, Board of Directors
2018 - Current

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The firm's progenitor cell activation approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Member, Board of Directors
2017 - Current

Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Independent Director
2015 - Current

MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. It focuses on inherited retinal diseases, neurodegenerative diseases, and severe forms of xerostomia. It operates through the following geographical segments: United States, Ireland, Netherlands, and United Kingdom. Its pipeline includes AAV CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

2018 - Current

To develop educated student leaders and serve as a college access hub in Durham, NC

Member, Board of Directors
2018 - Current

Navy SEAL Foundation is a 501(c)(3),tax exempt, national, non-profit benevolent organization headquartered in Virginia Beach, VA. The Foundation is a resolute cornerstone for the Naval Special Warfare community and their families in times of adversity and triumph. Established to serve U.S. Navy SEALs, Special Warfare Combatant-craft Crewmen, Naval Special Warfare (NSW) support personnel, and their families, the Navy SEAL Foundation provides a comprehensive set of programs specifically designed to reduce the stressors associated with the tremendous amount of uncertainty and pressure that comes with life in Naval Special Warfare (NSW).

2014 - Current

Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD.

Political Donations

Senator at Office of the Senator from Utah, Mitt Romney


Director, Public Affairs at Foley & Lardner LLP

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
National Association for Industrial and Office Parks - Developer of the Year, The Forum for Commercial Real Estate
CPA (Certified Public Accountant)
Ernst & Young - Entrepreneur of the Year
Other Affiliations

Joel S. Marcus is affiliated with Brobeck, Phleger & Harrison LLP, Arthur Young & Co., Accelerator Services Corp., Alexandria Equities LLC, Kirin-Amgen, Inc., Alexandria Summit, Alexandria Real Estate Equities, Inc., Alexandria Venture Investments LLC, Frequency Therapeutics, Inc., Applied Therapeutics, Inc., Meiragtx Holdings Plc, Intra-Cellular Therapies, Inc., Alexandria Real Estate Equities, Inc., Alexandria Venture Investments LLC, Boragen, Inc., BioRelix, Inc., Accelerator Services Corp., Cydan II, Inc., Imara, Inc., Atara Biotherapeutics, Inc., Rexford Industrial Realty, Inc., PennyMac Mortgage Investment Trust, Yumanity, Inc., Intra-Cellular Therapies, Inc. (Inactive), Lodo Therapeutics Corp., Petra Pharma Corp., Pinta Biotherapeutics, Inc., Rodeo Therapeutics Corp., W Fund Management LLC, Yumanity Holdings LLC, New York University - REIT Center at Schack Institute of Real Estate, Santa Maria Biotherapeutics, Inc., ISB Accelerator Corp., Nina Biotherapeutics, Inc., Medblue Incubator, Inc., MeiraGTx Ltd., ITI, Inc. (New York), Agtech Accelerator Corp., Boston Biomedical, Inc., The Emily Krzyzewski Family Life Center, Navy SEAL Foundation, Inc., Biohealth Innovation, Inc., Foundation for the National Institutes of Health, Inc., The Parker Institute for Cancer Immunotherapy, National September 11 Memorial & Museum at the World Trade Center Foundation, Inc., The Partnership for New York City, Massachusetts Biotechnology Council, The National Medal of Honor Museum Foundation, The Scripps Research Institute - California, Robin Hood Foundation, Biotechnology Innovation Organization, National Association of Real Estate Investment Trusts, Inc., The Multiple Myeloma Research Foundation, Inc., Friends of Cancer Research, Multiple Myeloma Research Consortium, New York Biotechnology Association, Inc., The Partnership Fund for New York City, The Hamner Institutes for Health Sciences, New York University - Schack Institute of Real Estate at the School of Continuing and Professional Studies, NewYorkBIO

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joel S. Marcus. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joel S. Marcus's profile does not indicate a business or promotional relationship of any kind between RelSci and Joel S. Marcus.